Searched for
SALMETEROL
Glenmark Pharma launches COPD treatment inhaler in UKDrug firm Glenmark Pharma on Tuesday announced the launch of Tiotropium Bromide Dry Powder Inhaler, used in the treatment of chronic obstru...- Trending stocks: Cipla shares gain over 3%A total of 292,263 shares changed hands on the counter till 11:00AM (IST).
- Cipla submits application with USFDA for generic version of asthma drugDrug major Cipla on Monday said it has submitted an application with the US health regulator for a generic version of GSK's Advair Diskus, ...
- Market Movers: Lupin, Sun Pharma soar; RBL plunges; ‘buy’ signal in 171 stocksHere is a lowdown of the movers and shakers of Friday’s session on Dalal Street.
- Cipla jumps 8% on completing Phase-3 clinical study of asthma drugThe generic would be used for treatment of asthma and chronic obstructive pulmonary disease.
- Buy Neuland Laboratories, target Rs 920: HDFC SecuritiesNeuland Laboratories is a smallcap company, operating in pharmaceuticals and health care sector.
- Glenmark Pharma rallies on Germany marketing nodThe drug, Fluticasone/Salmeterol dry powder inhaler (DPI), is a generic version of GlaxoSmithKline’s Seretide Accuhaler.
- Glenmark inks licensing pact for generic Tiotropium Bromide dry powder inhaler in Western EuropeThis is the second inhalation product in-licensed by Glenmark for the European market after Fluticasone/Salmeterol dry powder inhaler, the ...
- Glenmark Pharma launches generic version of asthma drug in DenmarkThe product was developed by Celon Pharma and Glenmark has marketing and distribution rights for the product across 15 European countries.
- Buy Neuland Laboratories, target Rs 1000: HDFC SecuritiesBuy Neuland Laboratories Ltd. at a price target of Rs 1000..
- World Asthma Day: Long-term usage of inhalers can have adverse side effectsNot only prevalent in developed countries, but it is also a major problem in the developing countries.
- Thirteen stocks in focus on Monday, 26 December 2016Homegrown auto major Mahindra & Mahindra plans to increase prices of its vehicles by up to Rs 26,500 from January as it looks to partially ...
- Glenmark Pharmaceuticals inks pact with Celon for generic Seretide AccuhalerAs per the agreement, Glenmark has obtained semi-exclusive marketing and distribution rights of the product across 15 European countries
- GSK halves seretide price to take on CiplaAsthma patients may breathe easier as GSK has halved the prices of its Seretide inhaler in India to match that of Cipla’s competing brand S...
- Lupin ties up with Poland-based firm for generic asthama drugLupin has set up a dedicated centre of excellence for inhalation research in Florida after having hired top notch inhalation scientists las...
- Stock diagnosis: Is Cipla a good buy for investors post Q3?According to analysts, rollout of inhalers in Europe and supplies of esomeprazole (Nexium) to Teva will be key triggers for the stock in co...
- Cipla Ltd to market Serum Institute's paediatric vaccines in EuropeCipla has launched multiple respiratory products in Europe this year, and launch of some key inhalers is expected in 2015.
- Cipla announces commercial tie-up with UK's S&D PharmaPharmaceutical firm Cipla today announced commercial collaboration with UK-based S&D Pharma in the Czech Republic and Slovakia.
- Cipla surges on launch of anti-asthma inhaler in Germany, SwedenThe launch paves way for a re-rating of the stock as the drugmaker could look at other key markets like UK, France and Spain next, say anal...
- Brokerages raise Cipla's target price post inhaler launchAnalysts at Emkay Global Financial Services are of the view that the launch will have a strong positive impact on the company’s margins.
Load More
